Home Monitoring of Dry AMD Patients
A device used by patients helps detect early signs of CNV so treatment can be started early.
By Michael J. Elman, MD
Patients with dry age-related macular degeneration (AMD) typically see a retina specialist every 6 months or so, at which time they undergo optical coherence tomography (OCT) and a dilated fundus examination. However, neovascular disease can develop between visits, progressing silently and resulting in irreversible pathologic changes and visual acuity loss.
AT A GLANCE
• The ForeseeHome AMD Monitoring Program allows patients to monitor their AMD every day without dilation.
• Patients who generate an alert on the ForeseeHome test trigger a recall to their eye doctor’s office for additional diagnostic testing and examination.
• Medicare coverage of the ForeseeHome AMD Monitoring Program has removed cost barriers for eligible patients.
• ForeseeHome can detect changes suggestive of progression so that treatment can be initiated early.
With home monitoring now available, unpredictable and variable disease progression and attendant visual acuity loss can be minimized and even avoided in some cases. The ForeseeHome AMD Monitoring Program (Notal Vision) can detect changes in patients with dry AMD who are at high risk for progressing to choroidal neovascularization (CNV), usually before symptoms develop. ForeseeHome provides a mechanism with which to monitor patients’ AMD every day in their homes without intruding into their lives and without the need to dilate their pupils. The device can serve as a vital safety net, with the potential to catch early development of neovascularization so that treatment can be initiated early enough to preserve vision……..
Source: Retina Today